Natriumvalproaat Chrono Sandoz (Sodium Valproate)

Sodium Valproate, the active ingredient in Natriumvalproaat Chrono Sandoz, is an anticonvulsant (carbamate) presented as an oral tablet for oral use. It is employed to treat generalized and focal seizures, to stabilize mood in bipolar disorder, and to prevent migraine attacks.

GNH USA supplies Natriumvalproaat Chrono Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other regulated markets.

Sodium Valproate is indicated for several neurological and psychiatric conditions in which modulation of neuronal excitability and GABAergic activity is required to control seizures, mood swings, or migraine frequency.

Epilepsy (generalized and focal seizures): reduces seizure frequency and severity, helping patients achieve better seizure control. Bipolar disorder (mood stabilization): maintains mood stability and prevents manic or depressive episodes in adults. Migraine prophylaxis: lowers the number of migraine attacks and may lessen their intensity when used regularly.

Sodium Valproate may cause a range of adverse reactions, varying from mild to potentially serious.

Common Side Effects: - Nausea or stomach upset - Tremor or mild shaking - Weight gain or increased appetite - Drowsiness or fatigue

Serious or Rare Side Effects: - Liver toxicity, including hepatitis - Acute pancreatitis - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis

When prescribing Sodium Valproate, clinicians should observe several safety considerations to minimize risk.

Monitor liver function: perform baseline and periodic liver enzyme tests. Monitor blood counts: check platelet and white‑cell counts regularly. Avoid in pregnancy unless essential: discuss risks and benefits with the patient. Use caution in patients with mitochondrial disorders: increased risk of liver failure. Adjust dose in hepatic impairment: reduce dosage based on liver function. Store at room temperature: keep in the original pack, protect from moisture.

Sodium Valproate interacts with several medicines; awareness of these interactions helps prevent loss of efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: reduces valproate levels and increases toxicity risk. - Phenytoin: decreases valproate plasma concentration.

Moderate Interactions (Monitor Closely): - Aspirin: may increase bleeding risk. - Warfarin: valproate can enhance anticoagulant effect. - Oral contraceptives: valproate may reduce contraceptive efficacy.